🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
12/03/2015 0,4294 USD
11/12/2014 0,4294 USD
11/09/2014 0,4198 USD
12/06/2014 0,4198 USD
13/03/2014 0,4198 USD
12/12/2013 0,4198 USD
12/09/2013 0,4103 USD
13/06/2013 0,4103 USD
13/03/2013 0,4103 USD
13/12/2012 0,4103 USD
13/09/2012 0,4008 USD
13/06/2012 0,4008 USD
13/03/2012 0,4008 USD
13/12/2011 0,4008 USD
13/09/2011 0,3626 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/02/1971 1,29 1,31 1,29 1,30 +0,52% 1,15% 2.429.683
08/02/1971 1,30 1,30 1,29 1,29 -0,26% 0,90% 814.925
05/02/1971 1,29 1,30 1,29 1,30 +0,52% 1,29% 1.403.482
04/02/1971 1,27 1,29 1,27 1,29 +1,30% 1,30% 1.237.478
03/02/1971 1,28 1,28 1,27 1,27 -0,52% 0,65% 777.197
02/02/1971 1,27 1,28 1,27 1,28 +1,58% 1,31% 860.198
01/02/1971 1,26 1,27 1,26 1,26 -0,26% 1,32% 2.414.592
29/01/1971 1,27 1,27 1,25 1,26 -0,79% 1,43% 1.478.938
28/01/1971 1,28 1,29 1,27 1,27 -0,26% 1,55% 792.288
27/01/1971 1,29 1,29 1,26 1,28 -1,54% 1,80% 1.478.938
26/01/1971 1,30 1,30 1,29 1,30 +0,00% 1,03% 3.946.349
25/01/1971 1,31 1,31 1,29 1,30 -0,76% 1,65% 1.577.030
22/01/1971 1,30 1,31 1,30 1,31 +0,51% 0,64% 1.350.662
21/01/1971 1,29 1,30 1,29 1,30 +0,78% 1,16% 1.245.024
20/01/1971 1,28 1,29 1,28 1,29 +0,77% 0,91% 452.736
19/01/1971 1,27 1,29 1,26 1,28 +0,39% 1,69% 747.014
18/01/1971 1,29 1,30 1,27 1,27 -1,29% 1,67% 4.316.083
15/01/1971 1,28 1,30 1,28 1,29 +1,17% 1,69% 1.245.024
14/01/1971 1,27 1,28 1,26 1,28 +0,52% 1,05% 505.555
13/01/1971 1,27 1,27 1,27 1,27 +0,00% 0,53% 1.048.838
12/01/1971 1,26 1,27 1,26 1,27 +0,66% 0,66% 1.222.387
11/01/1971 1,26 1,26 1,25 1,26 +0,14% 0,66% 664.013
08/01/1971 1,26 1,26 1,25 1,26 -0,13% 0,79% 1.546.848
07/01/1971 1,26 1,26 1,25 1,26 +0,14% 0,92% 731.923
06/01/1971 1,26 1,26 1,26 1,26 +0,00% 0,40% 1.079.021
05/01/1971 1,26 1,26 1,26 1,26 +0,00% 0,66% 445.190
04/01/1971 1,29 1,29 1,26 1,26 -4,04% 2,32% 1.328.026
31/12/1970 1,29 1,31 1,29 1,31 +1,67% 1,80% 996.019
30/12/1970 1,26 1,29 1,26 1,29 +2,23% 2,23% 913.018
29/12/1970 1,25 1,27 1,25 1,26 +1,46% 1,19% 709.286